ロード中...
Hypersensitivity in ALK-positive lung cancers exposed to ALK inhibitors: a case of successful switch to an alternative ALK inhibitor and systematic review of the literature
Alectinib can cause rare, but severe hypersensitivity. The cross-reactivity between different ALK inhibitors is unknown and desensitization is the only reported management. We hereby report the first case of severe delayed hypersensitivity developed in a lung cancer patient treated by alectinib, who...
保存先:
| 出版年: | Lung Cancer (Auckl) |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6134951/ https://ncbi.nlm.nih.gov/pubmed/30233266 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S173948 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|